Human B-1 Cells and B-1 Cell Antibodies Change With Advancing Age

Abstract

Age-related deficits in the immune system have been associated with an increased incidence of infections, autoimmune diseases, and cancer. Human B cell populations change quantitatively and qualitatively in the elderly. However, the function of human B-1 cells, which play critical anti-microbial and housekeeping roles, have not been studied in the older age population. In the present work, we analyzed how the frequency, function and repertoire of human peripheral blood B-1 cells (CD19+CD20+CD27+CD38^low/intCD43+) change with age. Our results show that not only the percentage of B-1 cells but also their ability to spontaneously secrete IgM decreased with age. Further, expression levels of the transcription factors XBP-1 and Blimp-1 were significantly lower, while PAX-5, characteristic of non-secreting B cells, was significantly higher, in healthy donors over 65 years (old) as compared to healthy donors between 20 and 45 years (young). To further characterize the B-1 cell population in older individuals, we performed single cell sequencing analysis of IgM heavy chains from healthy young and old donors. We found reduced repertoire diversity of IgM antibodies in B-1 cells from older donors as well as differences in usage of certain VH and DH specific genes, as compared to younger. Overall, our results show impairment of the human B-1 cell population with advancing age, which might impact the quality of life and onset of disease within the elderly population.

Introduction

Life expectancy is rapidly increasing worldwide. However, age-related diseases such as atherosclerosis, cancer, autoimmunity, type-2 diabetes mellitus, and microbial infection still have an impact on morbidity and mortality of elderly adults. Further, aging is accompanied by broad structural and functional changes in the immune system, usually related to increased susceptibility to the aforementioned diseases (1) and to decreased response to vaccination (2, 3).

It has been demonstrated that advancing age exerts a strong influence on remodeling of the B cell compartment of the immune system [reviewed in (4)]. There are two primary branches within the B cell population: conventional B-2 cells and B-1 cells. In mice, B-1 and B-2 cells differ in function and development, with B-2 cells originating mainly from the bone marrow and B-1 cells mainly from fetal liver and to a lesser extent from adult bone marrow (5, 6). Conventional B-2 cells cooperate with T cells in the germinal center to provide high-affinity long lasting antibody responses (7). On the other hand, B-1 cells spontaneously secrete natural antibodies mainly against non-protein antigens in the absence of exogenous immunization. This feature allows B-1 cells to provide pre-existing, immediate defense to counteract microbial infection (8–10). Given that B-1 cells are among the first B cells to develop, and the fact that B-1 cells, particularly IgM-secreting B-1 cells, are already present before birth, B-1 cells may be considered as the principal B cells responsible for establishing a natural antibody repertoire and defense early in ontogeny. Furthermore, it has been suggested that the earliest waves of B-1 cells during ontogeny produce natural IgM that regulates both B-1 and B-2 cell development (11). Also, B-1 cell antibodies influence some chronic diseases, such as atherosclerosis [reviewed in (12)].

Unlike high-affinity antibodies produced by B-2 cells, antibodies secreted by B-1 cells in mice have a germ-line like structure, due to minimal insertion of non-template-encoded nucleotides (N-region addition) and little somatic hypermutation (13, 14). B-1 cell-derived antibodies are often autoreactive, and serve a homeostatic function in speeding disposal of apoptotic cell debris and noxious molecular species [reviewed in (15)]. As such, B-1 cell antibodies can protect against atherosclerosis and autoimmunity (16, 17). Further, B-1 cells are considered more effective antigen presenting cells (APCs) than B-2 cells, and B-1 cells, but not B-2 cells, stimulate CD4+ T cells to differentiate into Th17 effector cells (18).

In humans, B-1 cells have been identified as CD20+CD27+CD38^low/intCD43+ based on the fact that B cells with this phenotype fulfill key functional criteria characteristic of mouse B-1 cells, such as spontaneous antibody secretion (19, 20). This population has been evaluated in healthy donors and in patients with autoimmune diseases, suggesting a role for human B-1 cells in such situations (21). For example, the frequency of B-1 cells in patients with relapsing-remitting multiple sclerosis was decreased compared with healthy controls (22). Also, the human B cell population with the phenotype CD20+CD27+CD43+CD5- generates antibodies to capsular polysaccharides of Streptococcus pneumoniae (23) suggesting an important role of this population in fighting infection.

Several reports have shown changes in conventional B-2 cells during aging, both in mice and humans. There is a decline in total B cell number or frequency during aging, which is more clearcut in humans than in mice (4). Further, the proportion of different subtypes within the B-cell lineage changes with age. For example, marginal zone (MZ) B cells significantly decline in aged BALB/c mice (24) while there is an increase in age-associated B cells (ABCs) (25). This is more controversial in the human scenario: different subsets of B cells have been shown to increase or decrease during aging depending on the cell phenotype or age of the cohort (26, 27). Functionally, aging impacts the mature B cell antibody response to vaccination. After antigenic challenge, B cells from old individuals produce fewer antibodies (28) and are impaired in the ability to undergo class switch recombination (CSR) (29, 30) and somatic hypermutation (SHM) (31), as compared to young individuals. This is compounded by loss of diversity in the B cell repertoire (32). As a result, antibodies generated in both old mice and old humans are less protective compared with antibodies produced by young adults (33, 34).

On the other hand, the impact of aging on the frequency and function of B-1 cells has been less studied. The most noted feature of B-1 cells in the aging mouse immune system is a change in repertoire. For example, certain VH11-encoded PtC-binding IgH sequences increase progressively with age in the pre-immune B-1a IgH repertoire (35). Other important specificities of B-1 cells are phosphorylcholine (PC) (36) and pneumococcal capsular polysaccharides, antigens found on the cell walls of the bacteria Streptococcus pneumoniae (10, 37). These bacteria are responsible for pneumococcal infections which are dramatically increased in old relative to young adults (38). The importance of B-1a cells in protection against pneumococci is indicated by experiments showing that in the absence of B-1a cells animals were unable to survive infection because of the lack of natural IgM, especially anti-PC and anti-pneumococcal capsular polysaccharide (PPS)-3 (10). Natural anti-pneumococcal antibodies produced by B-1 cells are increasingly important in aging since in the old population the adaptive anti-pneumococcal antibody response generated after immunization is less protective both in mice and humans (38–42). However, it has been shown that protection afforded by natural serum IgM against pneumococcal infection in mice diminishes with advancing age (43). B-1 cells isolated from old mice produce antibodies with more N-addition than B-1 cells from young animals (43–45), which can contribute to the above mentioned impaired protection. Still, a comprehensive study of changes in human B-1 cells during normal aging is lacking.

In the current work we elucidated age-related changes in the human B-1 cell population. We found B-1 cell frequency significantly decreases with advancing age. Functional analysis showed the B-1 cell population from older donors contains fewer antibody secreting cells than does the B-1 cell population present in younger donors. Further, we found transcription factors involved in the “classical” immunoglobulin secretion pathway are differentially expressed in B-1 cells from young and old donors. Importantly, we found reduced IgM repertoire diversity in B-1 cells from older as compared to younger donors. However, there were no differences in B-1 cell IgM somatic hypermutation or N-addition between young and old donors. Thus, with advancing age there are fewer B-1 cells, a smaller fraction of which secrete IgM, that display diminished diversity. Overall, these data indicate a decline in B-1 cell functionality in older individuals that might compromise the ability to oppose age-related diseases such as microbial infection and atherosclerosis.

Materials and Methods

Human Samples

Adult peripheral blood samples were obtained by venipuncture from a total of 120 healthy donors (20–88 years), of which 58% were females and 42% males. Donors were selected on the basis of good health status and no reports of infection/immunization within 4 weeks of blood draws. This study was conducted in accordance with the World Medical Association's Declaration of Helsinki. Written informed consent was received from all donors. This study was approved by the North Shore-LIJ Health System Institutional Review Board.

Cell Isolation

Heparinized blood samples were processed immediately upon receipt. Human peripheral blood mononuclear cells (PBMCs) were isolated by density gradient centrifugation using lymphocyte separation medium (Cellgro). Mononuclear cells were washed in phosphate-buffered saline (PBS) containing 1 mM EDTA and resuspended in either cell-sorting buffer [0.5% bovine serum albumin (BSA) in PBS] or FACS buffer [2.5% fetal calf serum (FCS), 1 mM EDTA, 0.02% NaN3 in PBS].

Cell Sorting

PBMCs were treated with 5% normal mouse serum (NMS), stained with an antibody mixture consisting of anti–CD19-allophycocyanin-Alexa Fluor700, anti–CD27-allophycocyanin, anti–CD43-FITC, anti–CD38-PerCP-Cy5.5, anti–CD20-Pacific Blue, anti–CD3-PE-TexasRed, anti–CD4-PE-TexasRed, and anti–CD7-PE-TexasRed in cell-sorting buffer, and then stained with Aqua Live/Dead dye (Invitrogen). Fluorescence Minus One controls were used for CD43+ and CD27+ cell selection. After washing, cells were resuspended in cell-sorting buffer and sort-purified on an Influx instrument (BD). B-1 (CD19+CD20+CD27+CD38^low/intCD43+) cells were collected from the CD3/4/7 negative population as previously described (20), following the gating strategy represented in Supplementary Figure 1A. The average purity of purified B-1 cells post-sort was 85%. For single-cell antibody sequencing, purified B-1 cells were re-sorted immediately after the initial sort, according to CD19+CD20+CD27+CD38^low/intCD43+ expression applying FSC-H/FSC-W-based doublet discrimination and single sort mask settings (Supplementary Figure 1B).

Flow Cytometry

Single-cell suspensions of PBMCs were pre-incubated with NMS for 20 min and then labeled for 30 min at 4°C with the following antibodies in FACS buffer: anti–CD19-Alexa Fluor 700, anti–CD20-Pacific Blue, anti–CD3-PE-TexasRed, anti–CD4-PE-TexasRed, anti–CD7-PE-TexasRed, anti–CD27-allophycocyanin, anti–CD38-PerCP-Cy5.5, anti–CD43-allophycocyanin-Alexa Fluor 750, and Aqua Live/Dead dye. Expression of cell surface markers was analyzed with a Gallios flow cytometer and FlowJo Software v. 9.7.6 (Tree Star). Antibodies were purchased from Beckman Coulter, BD Biosciences, or Biolegend.

Enzyme-Linked Immunospot Assay (ELISPOT)

ELISPOT assays were used to detect antibody-secreting cells. Sort-purified cells (1–10 x 10³) were distributed on Multi-Screen-IP Plates (Millipore) precoated with goat anti–human IgM or goat anti–human IgG and then incubated in complete medium (RPMI medium supplemented with 10% FCS, 10 mM HEPES, 1 mM non-essential aminoacids, 2 mM L-glutamine, 1 mM pyruvate, and 50 μg/mL Penicillin/Streptomycin) for 18 h at 37°C and 5% CO₂. Plates were then incubated with alkaline phosphatase-conjugated goat anti-human IgM or anti-human IgG (Southern Biotech), and developed with VECTOR Blue, Alkaline Phosphatase Substrate Kit III (Vector Laboratories). Immunoglobulin-secreting B cells were enumerated using C.T.L ImmunoSpot software (Cellular Technology Limited).

Wright-Giemsa Staining

B-1 cell morphology was analyzed immediately after sorting by cytospin and Wright-Giemsa staining (Sigma-Aldrich) according to the manufacturer's protocol. Images were acquired on a Nikon E80i microscope or a Zeiss LSM 710. ImageJ/Fiji software was used for analysis.

Real Time PCR

Total RNA from sort-purified B-1 cells was isolated using RNeasy (QIAGEN). cDNA synthesis was achieved using iScript (BioRad) according to the manufacturer's protocol. Quantitative PCR reactions were conducted in an ABI 7,300 machine using reagents and primers (Taqman) from Life Technologies. Primers: GAPDH Hs02758991_g1, Blimp-1 (PRDM-1) Hs00153357_m1, XBP-1 Hs0231936_m1, and PAX-5 Hs00277134_m1.

Single-Cell RT-PCR and IGHM Analysis

Single cells were sorted into 96-well PCR plates containing 20 uL/well of ice-cold lysing buffer (40 U/μl RNaseOut, 0.1 M DTT, 0.4% IGEPAL, 1 mg/ml carrier RNA, and 1xRTIII buffer in dH₂O), as previously reported (20). cDNA was synthesized in the original sorting plate in a final volume of 22.75 μl using SuperScript III RT (200 U/μl), random hexamers (50 μM), and dNTP mix (10 mM). Reverse transcription (RT) was performed at 42°C for 10 min, 25°C for 10 min, 50°C for 60 min, and 94°C for 5 min as described by Tiller et al. (46). IgH gene transcripts were amplified by two rounds of nested PCR. Protocol and primers were adapted from Tiller et al. (46). Two or more sequences were considered part of a clonotype if there was 100% homology in the CDR-H3 aminoacid sequence. The sequencing data have been submitted to the National Center for Biotechnology Information's Genbank (http://www.ncbi.nlm.nih.gov/genbank/) under accession numbers MK433645–MK434149.

Statistics

Statistical analysis was carried out with GraphPad Prism 6.0 and SPSS 16.0 software. To examine differences between two or more groups, Mann-Whitney U-test and Dunn's test were used, respectively. To examine the relationships between two variables, Spearman's correlation analysis was performed. P-values for IgH gene repertoire analysis were calculated by Fisher's Exact Test and Chi-square test. Error bars represent standard error of the mean (SEM) unless otherwise indicated.

Results

Human B-1 Cells Decline With Advancing Age

The proportion of naïve and memory subsets within the human B cell compartment has been extensively studied [Reviewed in (47)]. However, data on age-related changes in the human B-1 cell (CD19+CD20+CD27+CD38^low/intCD43+) population remain scarce. Here, we analyzed total CD19+ B cells and B-1 cells in the peripheral blood of 87 healthy donors of different ages (20–88 years). We found that the percentage of total CD19+ B cells as a fraction of total lymphocytes significantly decreased with advancing age (Figure 1A and Supplementary Figure 2A), consistent with previous reports (48–52). Importantly, we found the fraction of B-1 cells in the total CD19+ B cell population significantly declined with increasing age (Figure 1B). After analyzing various regression models, we found our data do not follow a linear regression trend and instead are better fit by a cubic model (higher R-squared). B-1 cell percentages were also compared grouping samples from donors within different age ranges. This analysis confirms a decrease in B-1 cell frequency with aging, which starts to be significant after the age of 50 (Supplementary Figure 2B). Thus, with advancing age, B-1 cells decline as a fraction of the declining total B cell population.

Figure 1.

Human B-1 cells decline with advancing age. PBMCs isolated from 87 healthy donors (20–88 years) were analyzed by flow cytometry for total CD19+ B cells (A) or B-1 cells (CD19+CD20+CD27+CD38^low/intCD43+) (B). (A,B) Data plotted in each diagram represent CD19+ B cells given as percent lymphocytes (A) and B-1 cells given as percent CD19+ B cells (B), each as a function of donor age. Spearman's r for each correlation and significance are the following: CD19+ B cells: r = −0.2997, p = 0.0053; B-1 cells: r = −0.3351, p = 0.0015. The solid line through the data points refers to a cubic regression curve fit.

Human B-1 Cell Spontaneous Antibody Secretion Declines With Advancing Age

One of the most important functions of B-lymphocytes is their ability to secrete antibodies. B-1 cells spontaneously secrete IgM and IgG antibodies, which are essential to fight infection (10, 43, 53), and have been related to the pathology of autoimmunity and other diseases (54, 55). Therefore, we investigated whether the ability of B-1 cells to spontaneously secrete antibodies changes with increasing age. Circulating B-1 cells from young (20–45 years) and old (65–88 years) donors were sort-purified and examined for spontaneous IgM and IgG secretion by ELISPOT assay. B-1 cells from both young and old donors spontaneously secreted IgM and IgG antibodies (Figures 2A,B). However, the percentage of B-1 cells spontaneously secreting IgM significantly decreased in old age compared with the young group while the frequency of IgG-secreting B-1 cells from older donors was no different from that of younger donors (Figure 2B). We also compared the amount of IgM or IgG secreted by each individual B-1 cell by calculating mean spot size. B-1 cells from young and old donors secreted similar amounts of IgM per secreting cell (Figure 2C). In contrast, on average, B-1 cells from older donors spontaneously secreted less IgG per secreting cell, compared with B-1 cells from younger individuals (Figure 2C). Thus, the age-related loss of B-1 cells (Figure 1) includes disproportionate loss of IgM-secreting B-1 cells and impaired secretion by an unchanging number of IgG producing cells (Figure 2).

Figure 2.

Human B-1 cell spontaneous antibody secretion declines with advancing age. Sort-purified circulating B-1 cells were plated and analyzed for spontaneous IgM and IgG secretion by ELISPOT. (A) ELISPOT images corresponding to four different representative donors (2 young and 2 old) are shown. Each sample was tested in duplicate. The number of cells that were plated in each well is indicated. (B) Plots show the frequency of IgM- or IgG-secreting B-1 cells from young (n = 10–18) and old (n = 8–11) donors measured and analyzed by ImmunoSpot software. (C) Plots show the mean spot size of IgM- or IgG-secreted antibodies for each young (n = 9–18) or old (n = 8–10) donor. ^*p < 0.05 by Mann–Whitney U-test, bars are standard errors of the means (SEM).

Human B-1 Cell Expression of Secretory Genes Changes With Advancing Age

Immunoglobulin secretion by conventional B-2 cells is controlled by a set of transcription factors including B lymphocyte inducer of maturation program 1 (Blimp-1) encoded by the PRDM-1 gene locus, Xbox binding protein-1 (XBP-1), and paired box gene 5 (PAX-5) (56). The mechanism of spontaneous immunoglobulin secretion by B-1 cells is only partially understood. However, some of these transcription factors have been shown to be involved in both mouse and human B-1 cell secretion (57, 58). To gain insight into the mechanism underlying downregulation of B-1 cell antibody secretion in aging, we determined whether B-1 cells from old donors exhibit alteration in expression of genes associated with antibody secretion by quantitative RT-PCR, as compared to B-1 cells from young donors. We found the expression levels of Blimp-1 (PRDM-1) and XBP-1, that promote immunoglobulin secretion, were significantly lower in the B-1 cell population isolated from old donors in contrast with B-1 cells from young donors (Figure 3). Further, with advancing age B-1 cells expressed increased levels of PAX-5, an inhibitor of the immunoglobulin secretory phenotype (Figure 3). Thus, the age-related impairment in B-1 cell immunoglobulin secretion could be related to age-related changes in expression of genes that regulate antibody secretion.

Figure 3.

Human B-1 cell expression of secretory genes changes with advancing age. B-1 cells from PBMCs were sort-purified and analyzed by RT-PCR for gene expression. The panels represent the relative expression of transcription factors related with B-cell secretory phenotype for 9–10 young and 7–8 old donors, normalized to GAPDH. ^*p < 0.05, ^**p < 0.01 by Mann–Whitney U-test, bars are mean and standard error of the mean (SEM).

Human B-1 Cell Morphology Changes With Advancing Age

Antibody secreting cells or plasma cells are characterized by a small, dense eccentrically placed nucleus and prominent cytoplasm, with abundant rough endoplasmic reticulum (RER) and enlarged Golgi. In contrast, non-secreting mature B cells have a high nucleus to cytoplasm ratio, little RER, and an uncondensed nucleus (59–61). To determine whether age-related changes in B-1 cell antibody secretion are reflected in morphological alterations, we examined the appearance of B-1 cells obtained from healthy young and old donors. We found that B-1 cells from young donors displayed morphologic characteristics typical of antibody-secreting cells, such as abundant cytoplasm and a small nucleus. On the other hand, the morphology of B-1 cells from old donors is closer to that of non-secreting B cells with a high nucleus to cytoplasm ratio (Figures 4A,B). Further, the frequency of B-1 cells with a lower nucleus to cytoplasm ratio is higher in each young donor as compared to each old donor (Figure 4C). These results are consistent with results obtained from ELISPOT and gene expression assays, and all together indicate cell-intrinsic defects in the immunoglobulin secretory pathway of B-1 cells accumulate with advancing age.

Figure 4.

Human B-1 cell morphology changes with advancing age. B-1 cells were sort-purified from PBMCs and stained with Wright–Giemsa stain. (A) Representative photomicrographs of B-1 cells from a young and an old donor are shown (magnification 60X). (B) Median nucleus/cytoplasm ratios of B-1 cells from young and old donors are shown. The diameters of the nucleus and the cytoplasm were measured by ImageJ software. Each dot represents the median of the nucleus/cytoplasm ratios calculated for each individual donor from the cells in 5–10 fields. ^*p < 0.05 by Mann–Whitney U-test, bars are means and standard errors of the means (SEM). (C) Frequency distributions of nucleus/cytoplasm ratios in B-1 cells from five young and 3 old donors are shown.

Effect of Age on the IgM IGHV Gene Repertoire of Circulating Human B-1 Cells

In humans, the general B cell repertoire of older individuals is characterized by decreased clonal diversity, reduced levels of mutation, and persistent clonal expansions (32, 62, 63). Although the B-1 cell repertoire in particular has been shown to significantly change with age in mice, little is known about equivalent changes in humans. Considering this, we studied age-related changes in the IgM B-1 cell repertoire in healthy humans of young and old age.

We single cell sorted circulating B-1 cells and amplified IgM heavy chain (IGHM) genes. A total of 572 sequences were generated from ten young (20–45 years) and ten old healthy donors (65–88 years). After quality control to ensure only productive, full-length sequences were represented, we obtained a total of 508 IgM sequences: 193 sequences for the young group and 315 sequences for the old group. Overall, a total of 384 unique V(D)J gene rearrangements were identified after heavy chain complementarity determining region 3 (CDR-H3) clustering. Of the 193 sequences obtained from young B-1 cells, 186 were unique sequences (93.6%), while of the 315 sequences obtained from old B-1 cells, 198 were unique sequences (62.8%) (Table 1). The median B-1 cell sequence/clone ratio among young donors was 1.05, with individual values ranging from 1.0 to 1.13 (Figure 5A). In the old donors, however, the sequence/clone ratio was significantly higher, with a median value of 2.11 with individual ratios ranging between 1.0 and 5.90 (Figure 5A). Considering individual donors, only 2 out of 10 B-1 cell samples from young donors had at least one expanded clonotype whereas 7 out of 10 B-1 cell samples from old donors had at least one expanded clonotype.

Table 1.

Numbers of IGHM sequences produced by single-cell PCR.

	Young (10 donors)	Old (10 donors)
Total IGHM sequences*	193	315
Unique IGHM rearrangements#s	186	198
Sequence/clone ratio†	1.04	1.59

^*The numbers represent the total of IGHM sequences that passed quality control with full immunoglobulin V(D)J gene rearrangement.

^#The numbers refer to unique sequences, where only one example per clone is counted. Two sequences were considered part of a clonotype if there was a 100% homology in the CDR-H3.

^†Represents the total number of IGHM sequences of all the young or old donors divided by the number of unique IGHM rearrangements.

Figure 5.

Human B-1 cell antibody diversity declines with advancing age. Single B-1 cells were sorted into 96-well plates, and IgM heavy chains (IGHM) were individually amplified for sequence analysis. IGHM genes were analyzed by IMGT V-QUEST and then clustered into clones by CDR-H3 DNA sequence similarity. (A) The total number of IGHM sequences of each donor sample divided by the number of unique IGHM rearrangements in the same sample (sequence/clone ratio) is shown for B-1 cell antibodies from young and old donors. ^*p < 0.05 by Mann–Whitney U-test, bars are means and standard errors of the means (SEM). (B) Tree map representation of IGHM repertoires from B-1 cells isolated from young (20–45 years) and old (65–88 years) donors, where each rectangle represents a unique V(D)J rearrangement and the area of each rectangle denotes the relative frequency of an individual sequence. Each graph represents the frequency of IGHM clonotypes in the B-1 cell pool from all the young (n = 10) or all the old (n = 10) donors. The numbers shown inside the rectangles indicate the sizes of the clones.

Among young donors, we found 3 clones shared between different individuals while in old donors we did not find any clonotype sharing. Further, four clones were shared between young and old donors. Three out of these four clones were part of expanded clonotypes in either young or old B-1 cells (Table 2). The IgH CDR-H3 tree maps show that B-1 cells from young donors had a highly diverse repertoire (Figure 5B). In contrast, CDR-H3 sequences expressed by B-1 cells from old donors were less diverse and recurred more frequently (Figure 5B). The recurrent CDR-H3 aminoacid sequences for both age groups are summarized in Table 2. Taken together, these data indicate that the B-1 cell IgHM repertoire changes with age and becomes more restricted and repetitive as compared to younger individuals, whose repertoire is more diverse.

Table 2.

Recurring CDR-H3 sequences (peptide and V(D)J recombination) in B-1 cells from young and old donors.

			IGHM CDR3 sequences
		Occurrence†	Peptide	V(D)J
YOUNG (20–45 YEARS) (n = 10)	1	2	ARAQGSSVDY	V3-21 D2-15 J4
	2	2	ARALGYYDSSGYDLPRIDY*	V3-13 D3-22 J4
	3	2	ARDPFADYLDY$*	V3-74 D3-10 J4
	4	2	ARDWDSSSRDYYGMDV*	V3-21 D6-13 J6
	5	2	ARGDPTLSSSSPLDY	V4-34 D6-6 J4
	6	3	AKDIGYTSSSGFDY$*	V3-9 D6-6 J4
OLD (65–88 YEARS) (n = 10)	1	2	AKDEGGGSGWPHYYYQYMDV	V3-9 D6-19 J6
	2	2	ARDQGSGSLHY	V1-3 D3-10 J4
	3	2	AREWLSNSYYYGMDV	V3-21 D3-22 J6
	4	2	AREYSSGWHFDY	V1-3 D6-19 J4
	5	2	ARGGGNWGYYFDS	V4-34 D4-23 J4
	6	2	ARGNYYGSGSYYFDS	V3-7 D3-10 J4
	7	2	ARKIVGATGDDGMDA	V4-34 D1-26 J6
	8	2	VRDAGTGYLDY	V3-30 D5-24 J4
	9	3	ARGGGSPGYSYEFDY	V4-34 D5-18 J4
	10	3	ARHSGWYPYYYMDV	V4-38 D3-10 J6
	11	3	ARSSRYGDYLDAFDI	V3-53 D4-17 J3
	12	3	ARWDCSSTSCVDY#	V3-30 D2-2 J4
				V3-15 D6-13 J2
	13	4	AKAAYGDYVSTYFDY	V3-30 D4-17 J4
	14	4	AREAFYCTNGLCYLNF	V1-46 D2-8 J4
	15	4	VRDGWGATSNNWFDP#	V3-7 D1-26 J5
				V3-15 D6-13 J2
	16	5	AMVGYYDTSGQSLDY	V1-18 D3-22 J4
	17	5	TTDLPVADYFQY	V3-15 D6-19 J1
	18	6	ARGDCRGGGCQSHFDS$	V3-33 D2-15 J4
	19	6	GTDSGAFDM	V3-73 D3-10 J3
	20	11	ARDAIIQYDC	V3-7 D2-8 J4
	21	28	TTVGSGSWFSWYFDL#	V3-15 D6-13 J2
				V1-8 D6-13 J2
				V3-7 D1-26 J5
				V3-21 D3-22 J4
				V3-30 D3-3 J6
				V4-38 D5-18 J4
	22	38	AGRGLYYDFWSGSTTDYYYMDV	V4-34 D3-9 J6

^†Times a CDR-H3 aminoacid sequence is present in the repertoire of all young or old donors.

^#The same CDR-H3 aminoacid sequence was encoded by different V(D)J recombination.

^$Clonotype sharing between B-1 cell repertoire from young and old donors.

^*Clonotype sharing between B-1 cell repertoire from more than one young (^*).

We quantified the frequency of IGHM sequences expressing individual V_H, D_H, and J_H genes for each sorted B-1 cell sample and then compared the usage of these segments between young and old donors. From this point onward, only one representative sequence per clone was used for analysis to reduce the influence of clonal expansion on the V_H, D_H, and J_H gene usage profile. We found B-1 cells from both young and old donors were similar in expressing mainly genes from the IGHV3 family as previously described for this B cell population (20). We also found similarity in use of the IGHD2, IGHD3, and IGHD6 families and the IGHJ4 gene family by B-1 cells from both young and old donors (Figure 6A). However, B-1 cell IgM sequences from old donors differed from those of young donors, at the gene family level, in increased use of IgHD3 and IgHJ2.

Figure 6.

VH, DH and JH gene segment usage frequencies within B-1 cells from young and old donors. Gene usage was calculated as the percentage of the total unique sequences for all the clones from young (n = 10) and old (n = 10) donors. From each clonotype only one representative sequence was considered for analysis. Relative frequencies of IGHV, IHGD, and IGHJ gene family (A), and individual IGHV and IGHD gene segment (B) usage are represented. ↑indicates a significant increase in IGHD or IGHJ gene family usage in the old B-1 population compared to the corresponding frequency in young B-1 cells. ^*p < 0.05, ^**p < 0.01, ^***p < 0.001 by χ² test or exact Fisher's test.

Further analysis of the young and old B-1 cell repertoires focused on individual gene segments (Figure 6B). An analysis of individual IGHV and IGHD genes showed a significant increase in IGHV3-53 and IGHD2-8 usage and a significant decrease in IGHV3-48, IGHD5-12, and IGHD6-6 usage with increasing age (Figure 6B). Thus, we identified some changes in IGHM gene segment usage associated with aging, both at the family and the individual gene level, although the significance of these changes within the context of the overall aging repertoire in terms of binding and function are at present unknown.

The CDR-H3 of immunoglobulin molecules is critical for specificity and affinity (64), so alterations in CDR-H3 properties could reflect selection for certain antigens. We compared CDR-H3 characteristics in IGH sequences from young and old B-1 cells. N-region addition provides junctional diversity to the CDR-H3 region through the addition of random nucleotides. Mouse B-1 cell antibodies have few N-additions early in life due to the lack of TdT enzyme during fetal B cell development, but later in life mouse B-1 cell antibodies contain N-additions (45). Human B cells possess N-additions due to constitutive expression of TdT as soon as 12 weeks after gestation (65) but changes with age in human B-1 cells have not been studied. We analyzed N-addition at the D–J and V–D junctions in B-1 cell antibodies from young and old donors. We found only a few antibody sequences did not have any N-addition at either junction (2–4%) and most of the sequences presented more than one N-addition at both junctions (>74%) (Figure 7A). No significant differences were found in the number of N-additions between young and old B-1 cell antibody sequences. We further examined CDR-H3 length and found old B-1 cell antibodies had more CDR-H3 with 13 and 15 aminoacids while young B-1 cell antibodies presented more CDR-H3 with 11 and 14 aminoacids (Figure 7B). However, the average CDR-H3 length did not differ significantly between young and old B-1 cell antibodies (p = 0.3570).

Figure 7.

Characterization of the CDR-H3 region in the B-1 cell IGHM repertoire. B-1 cells from 10 young and 10 old donors were single cell sorted and the IgM VH regions were amplified and sequenced. From each clonotype only one representative sequence was considered for analysis. (A) N-region addition analysis of B-1 cell IgM from young and old donors. The percentages of sequences with zero N-additions at both junctions, one or more N-additions at both junctions, zero N-additions at V-D and one or more at D-J junctions, or zero N-additions at D-J and one or more at V-D junctions are shown. (B) Length distribution of complementarity determining region 3 (CDR-H3) is shown for B-1 cell IgM antibodies from young and old donors. Inset shows the distribution of individual CDR-H3 length from young and old donors (C) The distribution of somatic mutations for B-1 cell IgM antibodies from young and old donors is shown as percent of sequences with zero or more than one nucleotide mutation. Inset shows the distribution of mutations for each sequence from young and old donors. n.s. p > 0.05 by Mann–Whitney U-test.

B-1 cell IgM antibodies have been shown to have SHM both in mice and humans. Further, the Herzenberg group has found that in mice both splenic and peritoneal B-1 cells accumulate SHM in the IgM repertoire as the animal age (35). Taking this into consideration, we hypothesized that the same might be happening in human B-1 cells. We analyzed somatic hypermutation in B-1 cell antibodies from young and old donors. We found a high percentage of B-1 cell antibody sequences from both young and old donors displayed more than one nucleotide mutation. B-1 cell antibodies without any mutation appear to be less frequent in older as compared to younger donors; further, B-1 cell antibodies with 10 or more mutations tend to be increased in the old group, but this difference did not reach the level of significance (Figure 7C). All together, these results suggest the structure of B-1 cell derived IgM does not change with age, although IgM repertoire diversity decreases significantly.

Discussion

Previous studies have shown that aging is characterized by significant changes in total B cells and some B cell subpopulations, resulting in age-related changes in antibody composition. However, little is known regarding age-related changes in human B-1 cells. The human B-1 cell phenotype has evolved over time. Early studies suggested that similar to mice, human B-1 cells express CD5 and are present at a higher frequency in human umbilical cord blood and fetal spleen than in adult peripheral blood and spleen (66). Further, human CD5-expressing B cells were reported to produce autoreactive IgM antibodies and to be increased in patients with autoimmune diseases (67, 68). However, CD5 is also present at a variable extent on different human B-cell populations, including transitional, pre-naïve, and activated B-cells (69–71). Further, not all B-1 cells in mice express CD5, as is the case of B-1b cells, suggesting that CD5+ alone is not sufficient to designate the human B-1 cell population. More recently, Griffin et al. proposed a novel phenotype for B-1 cells (CD20+CD27+CD43+) based on the fact that the population so defined fulfills key functional criteria for B-1 cells such as spontaneous antibody secretion (19). Since then, several independent groups have evaluated this circulating B cell population in healthy volunteers, during human fetal hematopoietic development, and in clinical conditions of common variable immunodeficiency, multiple sclerosis, bone marrow transplantation, and lupus (21, 22, 72–74). Here, we identified human B-1 cells as CD19+CD20+CD27+CD38^low/int CD43+, according to the more detailed phenotypic profile recently described by Quach et al. (20). In the present study, we found similar percentages of circulating B-1 cells to the ones reported before for this population (20, 22, 23). Although this is a small percentage, similar B-1 frequency has been detected for mouse splenic B-1 cells (75), which are responsible for most of the spontaneous IgM secretion in mice. In fact, we found that the circulating B-1 cells in humans are able to spontaneously secrete immunoglobulin and thus are likely to contribute to the natural antibody pool.

Our results show the percentage of B-1 cells within the total CD19+ B cell population decreases with advancing age. The age-related decline we detected in the human B-1 cell population as a fraction of total B cells is even more striking if the age-related decrease in total CD19+ cells is taken into account. This result is opposite to what has been observed in mice where B-1 cell number increases or remains unchanged with age (76). Mouse B-1 cells arise early in life from embryonic and fetal progenitors and are maintained later on by self-renewal and an unknown level of production from adult bone marrow precursors (45, 77–79). These processes appear not to be affected in a quantitative way in aged mice. Although little is known about human B-1 cell ontogeny, a recent report by Quach et al. showed human B-1 cells develop from umbilical cord blood Lin-CD34+CD38^lo stem cells after adoptive transfer to immunodeficient (NSG) mice. However, in the same study Lin-CD34+CD38^lo stem cells from adult bone marrow were much less effective in giving rise to B-1 cells (80). The frequency of common lymphoid progenitor cells (81) and, in particular, B cell progenitors (82) has been reported to decrease with age, and human hematopoietic stem cells from old donors, xenotransplanted into immunodeficient mice, do not generate lymphoid progeny as efficiently as stem cells from young donors (81). All together, these findings indicate that poor bone marrow production may be responsible, at least in part, for the age-related decline in total B cells. Thus, poor production of B-1 cells by human adult bone marrow progenitors may contribute to the decline in B-1 cell numbers with advancing age, and/or fail to compensate when B-1 cell numbers decline for other reasons.

It has been shown that aging affects not only the frequency but also the function of B cells (51). The main function of B-1 cells is the spontaneous secretion of antibody. Our results show this important function is adversely affected by age. We found the frequency of spontaneously IgM-secreting B-1 cells was reduced among B-1 cells obtained from old donors as compared to young donors. However, age did not affect the IgM secretion capacity of each individual B-1 cell, which was not impaired. Conversely, the frequency of spontaneously IgG-secreting B-1 cells didn't change as a function of age, but an age-related defect of each spontaneously IgG-secreting B-1 cell was apparent, resulting in less immunoglobulin production per cell. These results might suggest that the mechanism for spontaneous secretion of IgM and IgG by human B-1 cells is different and is affected differently by the aging process.

The mechanism underlying spontaneous secretion of natural antibodies by B-1 cells is not fully understood. Induction of Blimp-1 is one of the first steps required for the generation of antibody secreting plasma cells in mice and in humans (83–85). It has been reported that the mouse B-1 cell subpopulation spontaneously secretes antibodies by mechanisms that are both dependent on, and independent of, Blimp-1, and that work differently for IgM and IgG secretion. Savage et al. demonstrated that splenic B-1 cells spontaneously secreting natural antibodies are a heterogeneous population that contains both Blimp-1-positive B-1 cells and Blimp-1-negative B-1 cells. While both subsets secrete natural IgM, spontaneous IgG3 secretion by B-1 cells was mostly Blimp-1–independent, suggesting an alternative activation/differentiation pathway is used by Blimp-1-negative antibody-secreting cells (58). The mechanism of spontaneous immunoglobulin secretion by human B-1 cells has not been studied; thus, it is unknown whether mice and humans share similar pathways, nor whether human B-1 represent a heterogeneous population regarding the dependency on Blimp-1 for spontaneous secretion. A previous paper by Quach et al. reported that human B-1 cells express substantial levels of Blimp-1 (20), suggesting the importance of this molecule for spontaneous secretion by human B-1 cells. Our results showed that the level of Blimp-1 expression is lower in old B-1 cells as compared to young B-1 cells. Thus, the level of Blimp-1 could be related to a decrease in the frequency of B-1 cells that spontaneously secrete IgM and/or to the fact that old B-1 cells secrete less IgG antibody per cell. The difference we found in the behavior of IgM or IgG secreting B-1 cells with age may be explained by the existence of different pathways for IgM and IgG spontaneous secretion, as was reported for mice.

Blimp-1 deficiency during aging has been reported previously. Frasca et al. found a decrease in Blimp-1 expression in general CD19+ cells after 5–8 days of stimulation with CpG (86). In contrast, in our study we show a significant decrease of Blimp-1 expression in non-stimulated B-1 cells from old individuals compared with young. Our results may represent a defect in the spontaneous/basal expression of Blimp-1 in old B-1 cells which may explain their decreased capacity to spontaneously secrete immunoglobulin. Expression of 2 additional genes tied to antibody secretion also correlated with age-related diminution of B-1 cell antibody secretion: loss of XBP-1 and gain of PAX-5. As XBP-1 is under PAX-5 control and at the same time PAX-5 is regulated by Blimp-1, the difference in the expression levels of the former transcription factors in B-1 cells from old donors may in turn be explained by the observed decrease of Blimp-1 levels. The reason for decreased Blimp-1 mRNA expression in B-1 cells from old as compared to young donors could be due to up-regulation of Blimp-1 repressors (Bach2/MITF) and/or an age-associated down-regulation of the mRNA stability of Blimp-1. In both scenarios, micro-RNAs and other epigenetic modifications may be involved (87), given the fact that epigenetic regulation dramatically changes with age (88, 89) including in the B cell compartment (90, 91). Regardless of the molecular mechanism, with advancing age spontaneous natural antibody secretion by B-1 cells is reduced, in terms of the number of IgM-secreting B-1 cells and the amount of IgG secretion per cell. Further confirmation of age-related alteration in immunoglobulin secretion is provided by morphological changes that include increased nuclear/cytoplasmic ratio in old vs. young B-1 cells.

Next, we further analyzed B-1 IgM antibody repertoire changes during aging. We focused our study on IgM since natural antibodies with this isotype are the ones that have been extensively associated with natural protection against several diseases, many of which are more prevalent in the elderly, and have been associated with homeostatic control in numerous studies in mice and humans (10, 92–96). Beside a cell intrinsic defect in spontaneous immunoglobulin secretion, we found a reduction in IgM antibody heterogeneity among B-1 cells from old donors. There was an increase in the number and size of clones, and a corresponding decrease in the number of unique sequences with advancing age. Previously, Gibson et al. showed that repertoire diversity of total B cells decreases with age and is associated with poor health (32). However, until now there has been no information on the degree to which human B-1 cells participate in this change. In mice, certain splenic B-1a VDJ sequences become progressively more dominant with age (35), and peritoneal B-1a IgM antibody sequences acquire increased levels of N-addition in old animals (43, 45). The origin of these changes in the mouse B-1a repertoire remains unproven but may well result from antigen selection (35, 97, 98). The same may be true of human B-1 cell antibodies. That is, clonal expansion in old individuals may be an adaptive response to recurrent exposure to specific antigens. The decreased diversity of the B-1 cell IgM repertoire in old people might contribute to the weakness of natural antibodies in defense against infections of this population.

Two clones among old B-1 cell antibodies were particularly large (38 and 28 members, respectively). However, because each appeared in only one donor, we consider these subject-specific clones, and it cannot be concluded that these clones represent specificities that are generally increased across the population of older donors. Regardless, it would be of interest to determine the specificities that triggered expansion of these clones. Although definitive information is not available, it is notable that clone 22 (as refered in Table 2) shared 88% identity with an antibody reported in a study about human natural autoantibodies reacting with the α-subunit of the human high-affinity immunoglobulin E (IgE) receptor (FcεRIα) (99).

Discounting clonal expansion, that is, focusing only on unique sequences, there was very little difference in human B-1 cell IgM antibodies from healthy old vs. healthy young donors in terms of VH family usage. This is similar to the situation with human naïve B cells but different than other human B cell subsets (100), and may reflect continual self-renewal of a population established early in life. However, superimposed on this are several distinct differences in antibody usage of individual VH segments between young and old human B-1 cell antibodies, the origin and significance of which remains uncertain.

Contrasting with mouse, in humans, TdT is expressed throughout ontogeny (101). This explains the fact that newborn antibodies from both B-1 and B-2 cells contain N-additions (19, 65). This also might explain why we did not find any increase in the number of N-additions in the old B-1 cell repertoire. Further, the absence of an increased number of N-additions in the elderly corresponds with the similar length of IgM CDR-H3 in young and old B-1 cell antibodies. Although previous reports demonstrated that the old IgM repertoire contains less somatic mutation than the young (63), and that the function of activation-induced cytidine deaminase (AID) is impaired in old B cells as compared to young (51), we did not find any change in the level of SHM in the human B-1 IgM repertoire with age.

Overall our data show that the antibody repertoire of B-1 cells from healthy old individuals differs from that of healthy young individuals in ways that restrict diversity. Together with significant age-related decreases in B-1 cell frequency and IgM/IgG secretion, age-related changes in B-1 cells likely impact the quality of life of the older age population through loss of natural antibody protection.

Data Availability

The datasets generated for this study can be found in National Center for Biotechnology Information's Genbank, MK433645 - MK434149.

Author Contributions

NR-Z, TDQ, TLR, and AMH conceived the experiments. NR-Z, TDQ, and TJH carried out the experiments. NR-Z and AMH analyzed data. TLR and AMH oversaw the project. All authors were involved in writing the paper and had final approval of the submitted and published versions.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Supplementary Material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fimmu.2019.00483/full#supplementary-material

Supplementary Figure 1

Phenotypic analysis of human peripheral blood B-1 cells by flow cytometry. Lymphocyte-enriched peripheral blood samples were stained with antibodies specific for human CD3, CD4, CD7, CD19, CD20, CD27, CD38, and CD43, and with Aqua Live/Dead dye, and were analyzed by flow cytometry. (A) Gating strategy to analyse and purify human B-1 cells is shown. Lymphocytes were subjected to doublet discrimination. Singlet lymphocytes were plotted to exclude CD3, CD4, and CD7 positive cells and to gate on CD19+ B cells. B cells were plotted using CD20 in order to separate CD20+ B cells from CD20- plasma cells. CD20+ B cells were plotted using CD27 and CD38 in order to exclude CD38^high pre-plasmablasts. CD38^low/int were further resolved according to CD27 and CD43 expression with B-1 cells being those cells expressing both CD27 and CD43. Fluorescence Minus One controls were used for CD43+ and CD27+ cell selection. (B) Post-sort analysis and gating strategy for single-cell sorting is shown. For single-cell sorting, purified B-1 cells were re-sorted immediately after the first sorting process according to CD19+CD20+ CD27+CD38^low/intCD43+ expression applying FSC-H/FSC-W-based doublet discrimination and single sort mask settings.

Supplementary Figure 2

Human B-1 cells decline with advancing age. PBMCs isolated from 87 healthy donors (20–88 years) were analyzed by flow cytometry for total CD19+ B cells (A) or B-1 cells (CD19+CD20+CD27+CD38^low/intCD43+) (B). Distribution of B cells as percent of total lymphocytes (A) and B-1 cells as percent CD19+ B cells (B) per age range. Different letters represent statistically significant differences; p < 0.05, Kruskal-Wallis and Dunn's tests.